nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR1—Signaling Pathways—CALCR—osteoporosis	0.000663	0.00261	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTH1R—osteoporosis	0.000663	0.00261	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CNR2—osteoporosis	0.00066	0.0026	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CALCA—osteoporosis	0.000652	0.00257	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SOST—osteoporosis	0.000651	0.00256	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PTH—osteoporosis	0.00065	0.00256	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—IL1B—osteoporosis	0.000646	0.00254	CbGpPWpGaD
Octreotide—SSTR5—G alpha (i) signalling events—POMC—osteoporosis	0.000643	0.00253	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CNR2—osteoporosis	0.000633	0.00249	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTH—osteoporosis	0.000615	0.00242	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000611	0.0024	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—POMC—osteoporosis	0.000604	0.00238	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000601	0.00237	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SOST—osteoporosis	0.0006	0.00236	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CNR2—osteoporosis	0.0006	0.00236	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—POMC—osteoporosis	0.000593	0.00233	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CALCA—osteoporosis	0.000592	0.00233	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TNF—osteoporosis	0.00059	0.00232	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTH—osteoporosis	0.00059	0.00232	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CALCR—osteoporosis	0.000588	0.00232	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTH1R—osteoporosis	0.000588	0.00232	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—IL6—osteoporosis	0.000586	0.0023	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000576	0.00227	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PTH—osteoporosis	0.000576	0.00227	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CNR2—osteoporosis	0.000575	0.00226	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TLN1—osteoporosis	0.000572	0.00225	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—WNT1—osteoporosis	0.000564	0.00222	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—PTHLH—osteoporosis	0.000561	0.00221	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CNR2—osteoporosis	0.000561	0.00221	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MGLL—osteoporosis	0.00055	0.00216	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTH1R—osteoporosis	0.000543	0.00214	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CALCR—osteoporosis	0.000543	0.00214	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000542	0.00213	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—WNT1—osteoporosis	0.000541	0.00213	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—PTHLH—osteoporosis	0.000538	0.00212	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LRP5—osteoporosis	0.000537	0.00211	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PTH—osteoporosis	0.000532	0.00209	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MGLL—osteoporosis	0.000527	0.00207	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTH—osteoporosis	0.000523	0.00206	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—MYC—osteoporosis	0.000523	0.00206	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CNR2—osteoporosis	0.000518	0.00204	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LRP5—osteoporosis	0.000514	0.00202	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LRP6—osteoporosis	0.000513	0.00202	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000511	0.00201	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—PTHLH—osteoporosis	0.00051	0.00201	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CNR2—osteoporosis	0.00051	0.00201	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CALCA—osteoporosis	0.000494	0.00195	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—P4HB—osteoporosis	0.000493	0.00194	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LRP6—osteoporosis	0.000492	0.00194	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—PTHLH—osteoporosis	0.000489	0.00192	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PTH—osteoporosis	0.000483	0.0019	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTH—osteoporosis	0.00048	0.00189	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—WNT1—osteoporosis	0.000479	0.00189	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—PTHLH—osteoporosis	0.000477	0.00188	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IL6—osteoporosis	0.000477	0.00188	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CALCA—osteoporosis	0.000474	0.00187	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000472	0.00186	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RAP1A—osteoporosis	0.000471	0.00186	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CNR2—osteoporosis	0.000471	0.00185	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—TNF—osteoporosis	0.000469	0.00185	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CNR2—osteoporosis	0.000467	0.00184	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MGLL—osteoporosis	0.000467	0.00184	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—ADCY5—osteoporosis	0.000464	0.00183	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NFATC1—osteoporosis	0.00046	0.00181	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—POMC—osteoporosis	0.000458	0.0018	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LRP5—osteoporosis	0.000456	0.0018	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—DKK1—osteoporosis	0.000456	0.0018	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CALCA—osteoporosis	0.000449	0.00177	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000443	0.00174	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—WNT1—osteoporosis	0.000442	0.00174	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PTHLH—osteoporosis	0.000441	0.00173	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—WNT1—osteoporosis	0.000439	0.00173	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—POMC—osteoporosis	0.000439	0.00173	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000437	0.00172	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LRP6—osteoporosis	0.000436	0.00172	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTHLH—osteoporosis	0.000434	0.00171	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TLN1—osteoporosis	0.000433	0.00171	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MGLL—osteoporosis	0.000431	0.0017	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CALCA—osteoporosis	0.00043	0.00169	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FGA—osteoporosis	0.000427	0.00168	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—ADCY5—osteoporosis	0.000421	0.00166	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LRP5—osteoporosis	0.000421	0.00166	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CALCA—osteoporosis	0.00042	0.00165	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TLN1—osteoporosis	0.000415	0.00163	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LRP6—osteoporosis	0.000403	0.00158	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—PTHLH—osteoporosis	0.0004	0.00157	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTHLH—osteoporosis	0.000397	0.00156	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—BMP2—osteoporosis	0.000397	0.00156	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—POMC—osteoporosis	0.000389	0.00153	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FGB—osteoporosis	0.000389	0.00153	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CALCA—osteoporosis	0.000388	0.00153	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CALCA—osteoporosis	0.000382	0.0015	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—IL6—osteoporosis	0.000379	0.00149	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PSMA5—osteoporosis	0.000375	0.00148	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PSMA2—osteoporosis	0.000375	0.00148	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—P4HB—osteoporosis	0.000374	0.00147	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TLN1—osteoporosis	0.000368	0.00145	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTH—osteoporosis	0.000363	0.00143	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—POMC—osteoporosis	0.000359	0.00141	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—P4HB—osteoporosis	0.000358	0.00141	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000358	0.00141	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—RAP1A—osteoporosis	0.000357	0.00141	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CNR2—osteoporosis	0.000354	0.00139	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CALCA—osteoporosis	0.000352	0.00139	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—ADCY5—osteoporosis	0.000352	0.00138	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CALCA—osteoporosis	0.00035	0.00138	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NFATC1—osteoporosis	0.000348	0.00137	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTH—osteoporosis	0.000348	0.00137	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—DKK1—osteoporosis	0.000346	0.00136	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—RAP1A—osteoporosis	0.000342	0.00135	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—POMC—osteoporosis	0.000341	0.00134	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TLN1—osteoporosis	0.00034	0.00134	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CNR2—osteoporosis	0.00034	0.00134	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—ADCY5—osteoporosis	0.000337	0.00133	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NFATC1—osteoporosis	0.000334	0.00131	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—WNT1—osteoporosis	0.000333	0.00131	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—DKK1—osteoporosis	0.000331	0.0013	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FGA—osteoporosis	0.000324	0.00128	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—WNT1—osteoporosis	0.000319	0.00126	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—ADCY5—osteoporosis	0.000319	0.00126	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KL—osteoporosis	0.000318	0.00125	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—P4HB—osteoporosis	0.000318	0.00125	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FGA—osteoporosis	0.000311	0.00122	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—POMC—osteoporosis	0.00031	0.00122	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PTH—osteoporosis	0.000309	0.00122	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—ADCY5—osteoporosis	0.000306	0.0012	CbGpPWpGaD
Octreotide—Pruritus—Estropipate—osteoporosis	0.000306	0.00041	CcSEcCtD
Octreotide—Discomfort—Zoledronate—osteoporosis	0.000306	0.00041	CcSEcCtD
Octreotide—Asthenia—Alendronate—osteoporosis	0.000306	0.00041	CcSEcCtD
Octreotide—Hypersensitivity—Ibandronate—osteoporosis	0.000305	0.00041	CcSEcCtD
Octreotide—Cough—Conjugated Estrogens—osteoporosis	0.000305	0.00041	CcSEcCtD
Octreotide—Dyspnoea—Risedronate—osteoporosis	0.000305	0.000408	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—RAP1A—osteoporosis	0.000304	0.0012	CbGpPWpGaD
Octreotide—Convulsion—Conjugated Estrogens—osteoporosis	0.000303	0.000407	CcSEcCtD
Octreotide—Dry mouth—Zoledronate—osteoporosis	0.000303	0.000406	CcSEcCtD
Octreotide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000303	0.000406	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—IL6R—osteoporosis	0.000302	0.00119	CbGpPWpGaD
Octreotide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000302	0.000405	CcSEcCtD
Octreotide—Pruritus—Alendronate—osteoporosis	0.000301	0.000404	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CNR2—osteoporosis	0.000301	0.00119	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PTHLH—osteoporosis	0.000301	0.00119	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—BMP2—osteoporosis	0.000301	0.00119	CbGpPWpGaD
Octreotide—Dyspepsia—Risedronate—osteoporosis	0.000301	0.000403	CcSEcCtD
Octreotide—Tinnitus—Estradiol—osteoporosis	0.0003	0.000402	CcSEcCtD
Octreotide—Constipation—Ethinyl Estradiol—osteoporosis	0.0003	0.000402	CcSEcCtD
Octreotide—Hypersensitivity—Calcitriol—osteoporosis	0.000299	0.000401	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—ADCY5—osteoporosis	0.000299	0.00118	CbGpPWpGaD
Octreotide—Cardiac disorder—Estradiol—osteoporosis	0.000299	0.0004	CcSEcCtD
Octreotide—Flushing—Estradiol—osteoporosis	0.000299	0.0004	CcSEcCtD
Octreotide—Myalgia—Conjugated Estrogens—osteoporosis	0.000298	0.0004	CcSEcCtD
Octreotide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000298	0.0004	CcSEcCtD
Octreotide—Chest pain—Conjugated Estrogens—osteoporosis	0.000298	0.0004	CcSEcCtD
Octreotide—Asthenia—Ibandronate—osteoporosis	0.000297	0.000399	CcSEcCtD
Octreotide—Anxiety—Conjugated Estrogens—osteoporosis	0.000297	0.000398	CcSEcCtD
Octreotide—Nausea—Etidronic acid—osteoporosis	0.000297	0.000398	CcSEcCtD
Octreotide—Oedema—Zoledronate—osteoporosis	0.000297	0.000398	CcSEcCtD
Octreotide—Anaphylactic shock—Zoledronate—osteoporosis	0.000297	0.000398	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—NFATC1—osteoporosis	0.000296	0.00117	CbGpPWpGaD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000296	0.000397	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000296	0.000397	CcSEcCtD
Octreotide—Diarrhoea—Estropipate—osteoporosis	0.000296	0.000397	CcSEcCtD
Octreotide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000295	0.000395	CcSEcCtD
Octreotide—Infection—Zoledronate—osteoporosis	0.000295	0.000395	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—FGB—osteoporosis	0.000295	0.00116	CbGpPWpGaD
Octreotide—Fatigue—Risedronate—osteoporosis	0.000295	0.000395	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—DKK1—osteoporosis	0.000294	0.00116	CbGpPWpGaD
Octreotide—Insomnia—Pamidronate—osteoporosis	0.000294	0.000394	CcSEcCtD
Octreotide—Pruritus—Ibandronate—osteoporosis	0.000293	0.000393	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—P4HB—osteoporosis	0.000293	0.00115	CbGpPWpGaD
Octreotide—Pain—Risedronate—osteoporosis	0.000292	0.000392	CcSEcCtD
Octreotide—Constipation—Risedronate—osteoporosis	0.000292	0.000392	CcSEcCtD
Octreotide—Shock—Zoledronate—osteoporosis	0.000292	0.000391	CcSEcCtD
Octreotide—Paraesthesia—Pamidronate—osteoporosis	0.000292	0.000391	CcSEcCtD
Octreotide—Diarrhoea—Alendronate—osteoporosis	0.000291	0.000391	CcSEcCtD
Octreotide—Asthenia—Calcitriol—osteoporosis	0.000291	0.00039	CcSEcCtD
Octreotide—Nervous system disorder—Zoledronate—osteoporosis	0.000291	0.00039	CcSEcCtD
Octreotide—Immune system disorder—Estradiol—osteoporosis	0.000291	0.00039	CcSEcCtD
Octreotide—Thrombocytopenia—Zoledronate—osteoporosis	0.000291	0.000389	CcSEcCtD
Octreotide—Dyspnoea—Pamidronate—osteoporosis	0.00029	0.000388	CcSEcCtD
Octreotide—Tachycardia—Zoledronate—osteoporosis	0.00029	0.000388	CcSEcCtD
Octreotide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000289	0.000387	CcSEcCtD
Octreotide—Somnolence—Pamidronate—osteoporosis	0.000289	0.000387	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PTHLH—osteoporosis	0.000289	0.00114	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—BMP2—osteoporosis	0.000289	0.00114	CbGpPWpGaD
Octreotide—Skin disorder—Zoledronate—osteoporosis	0.000288	0.000386	CcSEcCtD
Octreotide—Pruritus—Calcitriol—osteoporosis	0.000287	0.000385	CcSEcCtD
Octreotide—Hyperhidrosis—Zoledronate—osteoporosis	0.000287	0.000385	CcSEcCtD
Octreotide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000287	0.000384	CcSEcCtD
Octreotide—Diarrhoea—Raloxifene—osteoporosis	0.000287	0.000384	CcSEcCtD
Octreotide—Dyspepsia—Pamidronate—osteoporosis	0.000286	0.000383	CcSEcCtD
Octreotide—Dizziness—Estropipate—osteoporosis	0.000286	0.000383	CcSEcCtD
Octreotide—Oedema—Conjugated Estrogens—osteoporosis	0.000286	0.000383	CcSEcCtD
Octreotide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000286	0.000383	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PTH—osteoporosis	0.000285	0.00112	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PSMA5—osteoporosis	0.000285	0.00112	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—PSMA2—osteoporosis	0.000285	0.00112	CbGpPWpGaD
Octreotide—Alopecia—Estradiol—osteoporosis	0.000284	0.000381	CcSEcCtD
Octreotide—Infection—Conjugated Estrogens—osteoporosis	0.000284	0.000381	CcSEcCtD
Octreotide—Diarrhoea—Ibandronate—osteoporosis	0.000284	0.00038	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—WNT1—osteoporosis	0.000283	0.00111	CbGpPWpGaD
Octreotide—Anorexia—Zoledronate—osteoporosis	0.000283	0.000379	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—FGB—osteoporosis	0.000283	0.00111	CbGpPWpGaD
Octreotide—Decreased appetite—Pamidronate—osteoporosis	0.000282	0.000379	CcSEcCtD
Octreotide—Mental disorder—Estradiol—osteoporosis	0.000282	0.000378	CcSEcCtD
Octreotide—Dizziness—Alendronate—osteoporosis	0.000282	0.000378	CcSEcCtD
Octreotide—Shock—Conjugated Estrogens—osteoporosis	0.000281	0.000377	CcSEcCtD
Octreotide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00028	0.000376	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—RAP1A—osteoporosis	0.00028	0.0011	CbGpPWpGaD
Octreotide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00028	0.000376	CcSEcCtD
Octreotide—Malnutrition—Estradiol—osteoporosis	0.00028	0.000376	CcSEcCtD
Octreotide—Erythema—Estradiol—osteoporosis	0.00028	0.000376	CcSEcCtD
Octreotide—Fatigue—Pamidronate—osteoporosis	0.00028	0.000375	CcSEcCtD
Octreotide—Gastrointestinal pain—Risedronate—osteoporosis	0.000279	0.000375	CcSEcCtD
Octreotide—Tachycardia—Conjugated Estrogens—osteoporosis	0.000279	0.000374	CcSEcCtD
Octreotide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000278	0.000373	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CNR2—osteoporosis	0.000278	0.00109	CbGpPWpGaD
Octreotide—Pain—Pamidronate—osteoporosis	0.000278	0.000372	CcSEcCtD
Octreotide—Constipation—Pamidronate—osteoporosis	0.000278	0.000372	CcSEcCtD
Octreotide—Diarrhoea—Calcitriol—osteoporosis	0.000278	0.000372	CcSEcCtD
Octreotide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000278	0.000372	CcSEcCtD
Octreotide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000277	0.000371	CcSEcCtD
Octreotide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000277	0.000371	CcSEcCtD
Octreotide—Dizziness—Raloxifene—osteoporosis	0.000277	0.000371	CcSEcCtD
Octreotide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000276	0.00037	CcSEcCtD
Octreotide—Flatulence—Estradiol—osteoporosis	0.000276	0.00037	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—ADCY5—osteoporosis	0.000276	0.00109	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGA—osteoporosis	0.000275	0.00108	CbGpPWpGaD
Octreotide—Tension—Estradiol—osteoporosis	0.000275	0.000369	CcSEcCtD
Octreotide—Vomiting—Estropipate—osteoporosis	0.000275	0.000369	CcSEcCtD
Octreotide—Dizziness—Ibandronate—osteoporosis	0.000274	0.000368	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—NFATC1—osteoporosis	0.000273	0.00108	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PSMA5—osteoporosis	0.000273	0.00107	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PSMA2—osteoporosis	0.000273	0.00107	CbGpPWpGaD
Octreotide—Rash—Estropipate—osteoporosis	0.000273	0.000365	CcSEcCtD
Octreotide—Dermatitis—Estropipate—osteoporosis	0.000272	0.000365	CcSEcCtD
Octreotide—Anorexia—Conjugated Estrogens—osteoporosis	0.000272	0.000365	CcSEcCtD
Octreotide—Nervousness—Estradiol—osteoporosis	0.000272	0.000365	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—ADCY5—osteoporosis	0.000271	0.00107	CbGpPWpGaD
Octreotide—Urticaria—Risedronate—osteoporosis	0.000271	0.000364	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—DKK1—osteoporosis	0.000271	0.00107	CbGpPWpGaD
Octreotide—Back pain—Estradiol—osteoporosis	0.000271	0.000363	CcSEcCtD
Octreotide—Headache—Estropipate—osteoporosis	0.000271	0.000363	CcSEcCtD
Octreotide—Vomiting—Alendronate—osteoporosis	0.000271	0.000363	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00027	0.000362	CcSEcCtD
Octreotide—Abdominal pain—Risedronate—osteoporosis	0.00027	0.000362	CcSEcCtD
Octreotide—Body temperature increased—Risedronate—osteoporosis	0.00027	0.000362	CcSEcCtD
Octreotide—Muscle spasms—Estradiol—osteoporosis	0.000269	0.000361	CcSEcCtD
Octreotide—Rash—Alendronate—osteoporosis	0.000269	0.00036	CcSEcCtD
Octreotide—Insomnia—Zoledronate—osteoporosis	0.000268	0.00036	CcSEcCtD
Octreotide—Dermatitis—Alendronate—osteoporosis	0.000268	0.00036	CcSEcCtD
Octreotide—Feeling abnormal—Pamidronate—osteoporosis	0.000268	0.000359	CcSEcCtD
Octreotide—Headache—Alendronate—osteoporosis	0.000267	0.000358	CcSEcCtD
Octreotide—Paraesthesia—Zoledronate—osteoporosis	0.000266	0.000357	CcSEcCtD
Octreotide—Vomiting—Raloxifene—osteoporosis	0.000266	0.000357	CcSEcCtD
Octreotide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000266	0.000356	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CALCA—osteoporosis	0.000265	0.00104	CbGpPWpGaD
Octreotide—Dyspnoea—Zoledronate—osteoporosis	0.000265	0.000355	CcSEcCtD
Octreotide—Rash—Raloxifene—osteoporosis	0.000264	0.000354	CcSEcCtD
Octreotide—Dermatitis—Raloxifene—osteoporosis	0.000264	0.000354	CcSEcCtD
Octreotide—Somnolence—Zoledronate—osteoporosis	0.000264	0.000354	CcSEcCtD
Octreotide—Vomiting—Ibandronate—osteoporosis	0.000264	0.000353	CcSEcCtD
Octreotide—Tremor—Estradiol—osteoporosis	0.000262	0.000352	CcSEcCtD
Octreotide—Headache—Raloxifene—osteoporosis	0.000262	0.000352	CcSEcCtD
Octreotide—Rash—Ibandronate—osteoporosis	0.000261	0.00035	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—WNT1—osteoporosis	0.000261	0.00103	CbGpPWpGaD
Octreotide—Dermatitis—Ibandronate—osteoporosis	0.000261	0.00035	CcSEcCtD
Octreotide—Dyspepsia—Zoledronate—osteoporosis	0.000261	0.00035	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00026	0.000349	CcSEcCtD
Octreotide—Ill-defined disorder—Estradiol—osteoporosis	0.00026	0.000349	CcSEcCtD
Octreotide—Headache—Ibandronate—osteoporosis	0.00026	0.000348	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—POMC—osteoporosis	0.000259	0.00102	CbGpPWpGaD
Octreotide—Insomnia—Conjugated Estrogens—osteoporosis	0.000258	0.000346	CcSEcCtD
Octreotide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000258	0.000346	CcSEcCtD
Octreotide—Vomiting—Calcitriol—osteoporosis	0.000258	0.000346	CcSEcCtD
Octreotide—Decreased appetite—Zoledronate—osteoporosis	0.000258	0.000346	CcSEcCtD
Octreotide—Agitation—Estradiol—osteoporosis	0.000257	0.000345	CcSEcCtD
Octreotide—Nausea—Estropipate—osteoporosis	0.000257	0.000344	CcSEcCtD
Octreotide—Abdominal pain—Pamidronate—osteoporosis	0.000257	0.000344	CcSEcCtD
Octreotide—Body temperature increased—Pamidronate—osteoporosis	0.000257	0.000344	CcSEcCtD
Octreotide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000257	0.000344	CcSEcCtD
Octreotide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000256	0.000343	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PTHLH—osteoporosis	0.000256	0.00101	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—BMP2—osteoporosis	0.000256	0.00101	CbGpPWpGaD
Octreotide—Rash—Calcitriol—osteoporosis	0.000256	0.000343	CcSEcCtD
Octreotide—Fatigue—Zoledronate—osteoporosis	0.000256	0.000343	CcSEcCtD
Octreotide—Dermatitis—Calcitriol—osteoporosis	0.000256	0.000343	CcSEcCtD
Octreotide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000255	0.000341	CcSEcCtD
Octreotide—Headache—Calcitriol—osteoporosis	0.000254	0.000341	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—FGA—osteoporosis	0.000254	0.001	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CALCA—osteoporosis	0.000254	0.001	CbGpPWpGaD
Octreotide—Somnolence—Conjugated Estrogens—osteoporosis	0.000254	0.000341	CcSEcCtD
Octreotide—Pain—Zoledronate—osteoporosis	0.000254	0.00034	CcSEcCtD
Octreotide—Constipation—Zoledronate—osteoporosis	0.000254	0.00034	CcSEcCtD
Octreotide—Nausea—Alendronate—osteoporosis	0.000253	0.000339	CcSEcCtD
Octreotide—Malaise—Estradiol—osteoporosis	0.000253	0.000339	CcSEcCtD
Octreotide—Hypersensitivity—Risedronate—osteoporosis	0.000252	0.000338	CcSEcCtD
Octreotide—Vertigo—Estradiol—osteoporosis	0.000252	0.000337	CcSEcCtD
Octreotide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000251	0.000337	CcSEcCtD
Octreotide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000251	0.000337	CcSEcCtD
Octreotide—Syncope—Estradiol—osteoporosis	0.000251	0.000337	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—FGB—osteoporosis	0.000251	0.000986	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—ADCY5—osteoporosis	0.000251	0.000986	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—ADCY5—osteoporosis	0.000249	0.000979	CbGpPWpGaD
Octreotide—Nausea—Raloxifene—osteoporosis	0.000249	0.000334	CcSEcCtD
Octreotide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000248	0.000333	CcSEcCtD
Octreotide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000248	0.000332	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—POMC—osteoporosis	0.000248	0.000976	CbGpPWpGaD
Octreotide—Palpitations—Estradiol—osteoporosis	0.000248	0.000332	CcSEcCtD
Octreotide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000247	0.000331	CcSEcCtD
Octreotide—Fatigue—Conjugated Estrogens—osteoporosis	0.000246	0.00033	CcSEcCtD
Octreotide—Nausea—Ibandronate—osteoporosis	0.000246	0.00033	CcSEcCtD
Octreotide—Loss of consciousness—Estradiol—osteoporosis	0.000246	0.00033	CcSEcCtD
Octreotide—Asthenia—Risedronate—osteoporosis	0.000245	0.000329	CcSEcCtD
Octreotide—Feeling abnormal—Zoledronate—osteoporosis	0.000245	0.000328	CcSEcCtD
Octreotide—Cough—Estradiol—osteoporosis	0.000244	0.000328	CcSEcCtD
Octreotide—Constipation—Conjugated Estrogens—osteoporosis	0.000244	0.000328	CcSEcCtD
Octreotide—Pain—Conjugated Estrogens—osteoporosis	0.000244	0.000328	CcSEcCtD
Octreotide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000243	0.000325	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PSMA5—osteoporosis	0.000242	0.000952	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—PSMA2—osteoporosis	0.000242	0.000952	CbGpPWpGaD
Octreotide—Hypertension—Estradiol—osteoporosis	0.000242	0.000324	CcSEcCtD
Octreotide—Pruritus—Risedronate—osteoporosis	0.000242	0.000324	CcSEcCtD
Octreotide—Nausea—Calcitriol—osteoporosis	0.000241	0.000323	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—SPP1—osteoporosis	0.000241	0.000948	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KL—osteoporosis	0.000241	0.000948	CbGpPWpGaD
Octreotide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00024	0.000321	CcSEcCtD
Octreotide—Hypersensitivity—Pamidronate—osteoporosis	0.000239	0.000321	CcSEcCtD
Octreotide—Arthralgia—Estradiol—osteoporosis	0.000239	0.00032	CcSEcCtD
Octreotide—Myalgia—Estradiol—osteoporosis	0.000239	0.00032	CcSEcCtD
Octreotide—Chest pain—Estradiol—osteoporosis	0.000239	0.00032	CcSEcCtD
Octreotide—Anxiety—Estradiol—osteoporosis	0.000238	0.000319	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000237	0.000318	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PTHLH—osteoporosis	0.000236	0.00093	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—BMP2—osteoporosis	0.000236	0.00093	CbGpPWpGaD
Octreotide—Urticaria—Zoledronate—osteoporosis	0.000236	0.000316	CcSEcCtD
Octreotide—Discomfort—Estradiol—osteoporosis	0.000236	0.000316	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—POMC—osteoporosis	0.000235	0.000924	CbGpPWpGaD
Octreotide—Abdominal pain—Zoledronate—osteoporosis	0.000235	0.000314	CcSEcCtD
Octreotide—Body temperature increased—Zoledronate—osteoporosis	0.000235	0.000314	CcSEcCtD
Octreotide—Diarrhoea—Risedronate—osteoporosis	0.000234	0.000313	CcSEcCtD
Octreotide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000234	0.000313	CcSEcCtD
Octreotide—Dry mouth—Estradiol—osteoporosis	0.000233	0.000313	CcSEcCtD
Octreotide—Asthenia—Pamidronate—osteoporosis	0.000233	0.000312	CcSEcCtD
Octreotide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000232	0.000311	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—FGB—osteoporosis	0.000231	0.00091	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KL—osteoporosis	0.000231	0.000909	CbGpPWpGaD
Octreotide—Pruritus—Pamidronate—osteoporosis	0.00023	0.000308	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—IL6R—osteoporosis	0.000229	0.000902	CbGpPWpGaD
Octreotide—Oedema—Estradiol—osteoporosis	0.000229	0.000307	CcSEcCtD
Octreotide—Anaphylactic shock—Estradiol—osteoporosis	0.000229	0.000307	CcSEcCtD
Octreotide—Infection—Estradiol—osteoporosis	0.000227	0.000305	CcSEcCtD
Octreotide—Urticaria—Conjugated Estrogens—osteoporosis	0.000227	0.000304	CcSEcCtD
Octreotide—Dizziness—Risedronate—osteoporosis	0.000226	0.000303	CcSEcCtD
Octreotide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000226	0.000303	CcSEcCtD
Octreotide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000226	0.000303	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CALCA—osteoporosis	0.000225	0.000887	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—POMC—osteoporosis	0.000225	0.000886	CbGpPWpGaD
Octreotide—Shock—Estradiol—osteoporosis	0.000225	0.000302	CcSEcCtD
Octreotide—Nervous system disorder—Estradiol—osteoporosis	0.000224	0.000301	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PSMA2—osteoporosis	0.000223	0.000879	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PSMA5—osteoporosis	0.000223	0.000879	CbGpPWpGaD
Octreotide—Tachycardia—Estradiol—osteoporosis	0.000223	0.000299	CcSEcCtD
Octreotide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000223	0.000299	CcSEcCtD
Octreotide—Diarrhoea—Pamidronate—osteoporosis	0.000222	0.000298	CcSEcCtD
Octreotide—Skin disorder—Estradiol—osteoporosis	0.000222	0.000298	CcSEcCtD
Octreotide—Hyperhidrosis—Estradiol—osteoporosis	0.000221	0.000296	CcSEcCtD
Octreotide—Rash—Ethinyl Estradiol—osteoporosis	0.000221	0.000296	CcSEcCtD
Octreotide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000221	0.000296	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—POMC—osteoporosis	0.00022	0.000865	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6R—osteoporosis	0.00022	0.000864	CbGpPWpGaD
Octreotide—Headache—Ethinyl Estradiol—osteoporosis	0.00022	0.000294	CcSEcCtD
Octreotide—Hypersensitivity—Zoledronate—osteoporosis	0.000219	0.000293	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—IRS2—osteoporosis	0.000218	0.000857	CbGpPWpGaD
Octreotide—Vomiting—Risedronate—osteoporosis	0.000217	0.000291	CcSEcCtD
Octreotide—Rash—Risedronate—osteoporosis	0.000215	0.000289	CcSEcCtD
Octreotide—Dermatitis—Risedronate—osteoporosis	0.000215	0.000289	CcSEcCtD
Octreotide—Dizziness—Pamidronate—osteoporosis	0.000215	0.000288	CcSEcCtD
Octreotide—Headache—Risedronate—osteoporosis	0.000214	0.000287	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—LEP—osteoporosis	0.000213	0.000839	CbGpPWpGaD
Octreotide—Asthenia—Zoledronate—osteoporosis	0.000213	0.000285	CcSEcCtD
Octreotide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00021	0.000282	CcSEcCtD
Octreotide—Pruritus—Zoledronate—osteoporosis	0.00021	0.000281	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000208	0.000279	CcSEcCtD
Octreotide—Nausea—Ethinyl Estradiol—osteoporosis	0.000208	0.000279	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CALCA—osteoporosis	0.000208	0.000819	CbGpPWpGaD
Octreotide—Insomnia—Estradiol—osteoporosis	0.000207	0.000277	CcSEcCtD
Octreotide—Vomiting—Pamidronate—osteoporosis	0.000207	0.000277	CcSEcCtD
Octreotide—Paraesthesia—Estradiol—osteoporosis	0.000205	0.000275	CcSEcCtD
Octreotide—Asthenia—Conjugated Estrogens—osteoporosis	0.000205	0.000275	CcSEcCtD
Octreotide—Rash—Pamidronate—osteoporosis	0.000205	0.000275	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—KL—osteoporosis	0.000205	0.000806	CbGpPWpGaD
Octreotide—Dermatitis—Pamidronate—osteoporosis	0.000205	0.000274	CcSEcCtD
Octreotide—Dyspnoea—Estradiol—osteoporosis	0.000204	0.000273	CcSEcCtD
Octreotide—Headache—Pamidronate—osteoporosis	0.000203	0.000273	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—ESR1—osteoporosis	0.000203	0.000801	CbGpPWpGaD
Octreotide—Somnolence—Estradiol—osteoporosis	0.000203	0.000273	CcSEcCtD
Octreotide—Diarrhoea—Zoledronate—osteoporosis	0.000203	0.000272	CcSEcCtD
Octreotide—Nausea—Risedronate—osteoporosis	0.000203	0.000272	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—POMC—osteoporosis	0.000203	0.000799	CbGpPWpGaD
Octreotide—Pruritus—Conjugated Estrogens—osteoporosis	0.000202	0.000271	CcSEcCtD
Octreotide—Dyspepsia—Estradiol—osteoporosis	0.000201	0.00027	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—POMC—osteoporosis	0.0002	0.000786	CbGpPWpGaD
Octreotide—Decreased appetite—Estradiol—osteoporosis	0.000199	0.000266	CcSEcCtD
Octreotide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000197	0.000265	CcSEcCtD
Octreotide—Fatigue—Estradiol—osteoporosis	0.000197	0.000264	CcSEcCtD
Octreotide—Dizziness—Zoledronate—osteoporosis	0.000196	0.000263	CcSEcCtD
Octreotide—Constipation—Estradiol—osteoporosis	0.000196	0.000262	CcSEcCtD
Octreotide—Pain—Estradiol—osteoporosis	0.000196	0.000262	CcSEcCtD
Octreotide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000195	0.000262	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—IL6R—osteoporosis	0.000195	0.000767	CbGpPWpGaD
Octreotide—Nausea—Pamidronate—osteoporosis	0.000193	0.000259	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—IRS1—osteoporosis	0.00019	0.000748	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KL—osteoporosis	0.000189	0.000744	CbGpPWpGaD
Octreotide—Dizziness—Conjugated Estrogens—osteoporosis	0.000189	0.000253	CcSEcCtD
Octreotide—Vomiting—Zoledronate—osteoporosis	0.000189	0.000253	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—ADCY5—osteoporosis	0.000189	0.000742	CbGpPWpGaD
Octreotide—Feeling abnormal—Estradiol—osteoporosis	0.000188	0.000253	CcSEcCtD
Octreotide—Rash—Zoledronate—osteoporosis	0.000187	0.000251	CcSEcCtD
Octreotide—Gastrointestinal pain—Estradiol—osteoporosis	0.000187	0.000251	CcSEcCtD
Octreotide—Dermatitis—Zoledronate—osteoporosis	0.000187	0.000251	CcSEcCtD
Octreotide—Headache—Zoledronate—osteoporosis	0.000186	0.000249	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—POMC—osteoporosis	0.000184	0.000725	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—POMC—osteoporosis	0.000183	0.00072	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SPP1—osteoporosis	0.000182	0.000718	CbGpPWpGaD
Octreotide—Vomiting—Conjugated Estrogens—osteoporosis	0.000182	0.000244	CcSEcCtD
Octreotide—Urticaria—Estradiol—osteoporosis	0.000182	0.000244	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—ADCY5—osteoporosis	0.000181	0.000712	CbGpPWpGaD
Octreotide—Body temperature increased—Estradiol—osteoporosis	0.000181	0.000242	CcSEcCtD
Octreotide—Abdominal pain—Estradiol—osteoporosis	0.000181	0.000242	CcSEcCtD
Octreotide—Rash—Conjugated Estrogens—osteoporosis	0.00018	0.000242	CcSEcCtD
Octreotide—Dermatitis—Conjugated Estrogens—osteoporosis	0.00018	0.000241	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—IL6R—osteoporosis	0.00018	0.000707	CbGpPWpGaD
Octreotide—Headache—Conjugated Estrogens—osteoporosis	0.000179	0.00024	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—IL6R—osteoporosis	0.000179	0.000703	CbGpPWpGaD
Octreotide—Nausea—Zoledronate—osteoporosis	0.000176	0.000236	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—IGF1—osteoporosis	0.000176	0.000693	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SPP1—osteoporosis	0.000175	0.000689	CbGpPWpGaD
Octreotide—Nausea—Conjugated Estrogens—osteoporosis	0.00017	0.000228	CcSEcCtD
Octreotide—Hypersensitivity—Estradiol—osteoporosis	0.000168	0.000226	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—IRS2—osteoporosis	0.000165	0.000649	CbGpPWpGaD
Octreotide—Asthenia—Estradiol—osteoporosis	0.000164	0.00022	CcSEcCtD
Octreotide—Pruritus—Estradiol—osteoporosis	0.000162	0.000217	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—LEP—osteoporosis	0.000161	0.000636	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ADCY5—osteoporosis	0.00016	0.000631	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IRS2—osteoporosis	0.000158	0.000623	CbGpPWpGaD
Octreotide—Diarrhoea—Estradiol—osteoporosis	0.000156	0.00021	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—SPP1—osteoporosis	0.000155	0.000611	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LEP—osteoporosis	0.000155	0.000609	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—ESR1—osteoporosis	0.000154	0.000607	CbGpPWpGaD
Octreotide—Dizziness—Estradiol—osteoporosis	0.000151	0.000203	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—ADCY5—osteoporosis	0.000148	0.000582	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—ESR1—osteoporosis	0.000148	0.000582	CbGpPWpGaD
Octreotide—Vomiting—Estradiol—osteoporosis	0.000145	0.000195	CcSEcCtD
Octreotide—Rash—Estradiol—osteoporosis	0.000144	0.000193	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—IRS1—osteoporosis	0.000144	0.000567	CbGpPWpGaD
Octreotide—Dermatitis—Estradiol—osteoporosis	0.000144	0.000193	CcSEcCtD
Octreotide—Headache—Estradiol—osteoporosis	0.000143	0.000192	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—SPP1—osteoporosis	0.000143	0.000564	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IRS2—osteoporosis	0.00014	0.000552	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—POMC—osteoporosis	0.000139	0.000546	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IRS1—osteoporosis	0.000138	0.000544	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LEP—osteoporosis	0.000137	0.00054	CbGpPWpGaD
Octreotide—Nausea—Estradiol—osteoporosis	0.000136	0.000182	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—IL6R—osteoporosis	0.000135	0.000533	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—osteoporosis	0.000135	0.00053	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IGF1—osteoporosis	0.000133	0.000525	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—POMC—osteoporosis	0.000133	0.000523	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—ESR1—osteoporosis	0.000131	0.000516	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6R—osteoporosis	0.00013	0.000511	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IRS2—osteoporosis	0.000129	0.00051	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IGF1—osteoporosis	0.000128	0.000504	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LEP—osteoporosis	0.000127	0.000499	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IRS1—osteoporosis	0.000122	0.000482	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—ESR1—osteoporosis	0.000121	0.000476	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—POMC—osteoporosis	0.000118	0.000464	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6R—osteoporosis	0.000115	0.000453	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IGF1—osteoporosis	0.000113	0.000447	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IRS1—osteoporosis	0.000113	0.000445	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—POMC—osteoporosis	0.000109	0.000428	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6R—osteoporosis	0.000106	0.000418	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—osteoporosis	0.000106	0.000416	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—osteoporosis	0.000106	0.000415	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IGF1—osteoporosis	0.000105	0.000412	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—osteoporosis	0.000102	0.000402	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—osteoporosis	9.78e-05	0.000385	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—osteoporosis	8.68e-05	0.000341	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—osteoporosis	8.02e-05	0.000316	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—osteoporosis	8.01e-05	0.000315	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—osteoporosis	8e-05	0.000315	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—osteoporosis	7.95e-05	0.000313	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—osteoporosis	7.69e-05	0.000303	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—osteoporosis	7.67e-05	0.000302	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—osteoporosis	6.82e-05	0.000268	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—osteoporosis	6.8e-05	0.000268	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—osteoporosis	6.29e-05	0.000248	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—osteoporosis	6.28e-05	0.000247	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—osteoporosis	6.03e-05	0.000237	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—osteoporosis	5.78e-05	0.000227	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—osteoporosis	5.13e-05	0.000202	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—osteoporosis	4.73e-05	0.000186	CbGpPWpGaD
